AS-OCT and IVCM parameters
| Group 1 | Group 2 | Controls | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AS-OCT | IVCM | AS-OCT | IVCM | AS-OCT | IVCM | ||||
| MIHSA (mm2) | MMD (cysts/mm2) | MMA (µm2) | MIHSA (mm2) | MMD (cysts/mm2) | MMA (µm2) | MIHSA (mm2) | MMD (cysts/mm2) | MMA (µm2) | |
| Baseline | 0.055±0.022 | 9.916±4.333 | 1698.98±1007.511 | 0.054±0.037 | 10.545±5.763 | 1830.58±1132.380 | 0.049±0.013 | 10.041±3.827 | 1737.651±815.566 |
| Day 30 | 0.102±0.044*‡ | 14.375±5.173*‡ | 2961.78±1256.151*‡ | 0.182±0.112*†‡ | 18.000±9.990 *†‡ | 3290.41±1728.301*†‡ | 0.050±0.010 | 10.151±3.747 | 1686.605±763.431 |
*p<0.05 vs baseline.
†p<0.05 vs group 1.
‡p<0.001 vs controls.
AS-OCT, anterior segment optical coherence tomography; IVCM, in vivo confocal microscopy; MIHSA, mean intra-scleral hyporeflective space area; MMA, mean microcysts area; MMD, mean microcysts density.